GO:1990547 mitochondrial phosphate ion transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990547 describes the transport of phosphate ions (Pi) across the mitochondrial inner membrane, a process essential for ATP synthesis and mitochondrial metabolism.
• The mitochondrial phosphate carrier (PiC, SLC25A3) is the primary protein responsible for Pi uptake into the mitochondrial matrix, functioning as a proton-coupled symporter [3, 8].
• PiC operates as a homodimer, and its transport activity depends on specific transmembrane helices and residues, as revealed by mutagenesis studies [4, 5].
• Phosphate transport is critical for oxidative phosphorylation, and its dysfunction is linked to mitochondrial diseases and cancer [1, 3].
• Research on this process employs knockout, point-mutation, and overexpression models to dissect the molecular mechanism and physiological roles [4, 8].
• Understanding mitochondrial phosphate transport provides insights into energy metabolism, cellular signaling, and potential therapeutic targets [1, 7].
Description
Mitochondrial phosphate ion transmembrane transport (GO:1990547) is the biological process that mediates the movement of inorganic phosphate (Pi) across the mitochondrial inner membrane, either into or out of the mitochondrial matrix. This transport is fundamental for mitochondrial energy metabolism, as Pi is a substrate for ATP synthesis by oxidative phosphorylation and is required for numerous biosynthetic pathways [3, 7]. The process is primarily carried out by the mitochondrial phosphate carrier (PiC), also known as SLC25A3, a member of the solute carrier family 25. PiC functions as a proton-coupled symporter, utilizing the proton gradient across the inner membrane to drive Pi uptake. Researchers study mitochondrial phosphate transport to understand how cells maintain phosphate homeostasis, how mitochondrial dysfunction contributes to disease, and how metabolic fluxes are regulated [1, 3]. The transport process is tightly linked to the proton motive force and is essential for ATP production, making it a key node in cellular bioenergetics. Dysregulation of phosphate transport has been implicated in cancer, neurodegeneration, and mitochondrial disorders. This article provides a comprehensive overview of GO:1990547, covering its definition, molecular mechanism, key genes, regulation, disease relevance, and experimental approaches. It is intended for researchers seeking to investigate this process using CRISPR-based models and other advanced techniques.
mitochondrial phosphate ion transmembrane transport At A Glance
| GO ID | GO:1990547 |
|---|---|
| GO term | mitochondrial phosphate ion transmembrane transport |
| Ontology | biological_process |
| Synonym | None |
| Major function | Transport of phosphate ions across the mitochondrial membrane |
| Cellular location | Mitochondrial inner membrane |
| Key transporter | Mitochondrial phosphate carrier (PiC/SLC25A3) |
| Associated diseases | Mitochondrial myopathies, cancer, neurodegenerative disorders |
| Research methods | Knockout, point mutation, knock-in, overexpression, transport assays |
What Is GO:1990547?
GO:1990547, mitochondrial phosphate ion transmembrane transport, is defined as the process in which a phosphate ion is transported across a mitochondrial membrane, into or out of the mitochondrion. This encompasses the movement of inorganic phosphate (Pi) across the inner mitochondrial membrane, typically mediated by specific transport proteins such as the mitochondrial phosphate carrier (PiC). The process is essential for maintaining phosphate balance within mitochondria and for supporting ATP synthesis.
Why Is mitochondrial phosphate ion transmembrane transport Important in Cell Biology?
Mitochondrial phosphate ion transmembrane transport is crucial for cellular energy metabolism because phosphate is a direct substrate for ATP synthase. Without efficient Pi uptake into the mitochondrial matrix, oxidative phosphorylation cannot proceed, leading to energy failure and cell death [3, 7]. Moreover, Pi transport influences mitochondrial calcium handling, reactive oxygen species production, and apoptotic signaling. Understanding this process is therefore fundamental to mitochondrial biology and has broad implications for diseases ranging from metabolic disorders to cancer.
• Essential for ATP synthesis: Pi is required for the phosphorylation of ADP to ATP in the mitochondrial matrix.
• Maintains phosphate homeostasis: Regulates intracellular Pi levels, which affect many metabolic pathways.
• Linked to mitochondrial diseases: Mutations in the phosphate carrier SLC25A3 cause mitochondrial phosphate carrier deficiency.
• Implicated in cancer: Altered phosphate transport supports tumor growth and metabolic reprogramming.
• Affects calcium signaling: Pi transport influences mitochondrial calcium uptake and cell death.
• Target for drug discovery: Transport inhibitors could modulate mitochondrial metabolism.
• Required for biosynthetic pathways: Pi is needed for nucleic acid and phospholipid synthesis.
• Model for transport mechanisms: PiC serves as a paradigm for mitochondrial carrier proteins [4, 5].
• Relevance to neurodegeneration: Mitochondrial dysfunction, including Pi transport, is observed in Parkinson's disease models.
• Provides insights into evolution: PiC is conserved from yeast to humans, facilitating genetic studies.
What Happens During mitochondrial phosphate ion transmembrane transport?
Phosphate Recognition and Binding
In simple terms: The transporter grabs a phosphate ion from one side of the membrane.
The mitochondrial phosphate carrier (PiC) binds inorganic phosphate (Pi) with high affinity on the cytosolic side of the inner membrane. This binding is facilitated by specific residues within the transport cavity, including those identified by mutagenesis studies [4, 8]. The binding site is thought to involve a protonated form of Pi (H2PO4-) to facilitate transport.
Conformational Change and Translocation
In simple terms: The transporter changes shape to move the phosphate across the membrane.
Upon Pi binding, PiC undergoes a conformational change that translocates the ion across the inner membrane. This process is thought to involve a rocker-switch mechanism typical of mitochondrial carriers, where the protein alternates between cytoplasmic and matrix-facing states [3, 4]. The transport is coupled to proton symport, utilizing the proton gradient.
Phosphate Release in the Matrix
In simple terms: The phosphate is released inside the mitochondria.
After translocation, Pi is released into the mitochondrial matrix, where it becomes available for ATP synthesis and other metabolic reactions. The release is driven by the lower proton concentration in the matrix and the conformational cycle of the carrier [3, 8].
Proton Coupling and Energy Requirement
In simple terms: The transport uses the proton gradient as an energy source.
Pi transport is coupled to proton movement, with a stoichiometry of one proton per phosphate ion. This symport mechanism exploits the proton motive force generated by the electron transport chain, ensuring efficient Pi uptake even against a concentration gradient. The proton path involves specific residues such as Glu137 and Asp39, as shown by mutagenesis [4, 8].
Key Genes Involved in GO:1990547 mitochondrial phosphate ion transmembrane transport
The following genes and proteins are central to mitochondrial phosphate ion transmembrane transport, based on experimental evidence from the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A3 (PiC) | Mitochondrial phosphate carrier; mediates Pi transport | Primary transporter; mutations cause mitochondrial phosphate carrier deficiency |
| SLC25A3 (isoform A) | Heart and muscle-specific isoform | Tissue-specific functions in energy-demanding tissues |
| SLC25A3 (isoform B) | Ubiquitous isoform | General housekeeping role in Pi transport |
| SLC25A4 (ANT1) | ADP/ATP carrier; indirectly affects Pi transport | Interacts with PiC for energy metabolism |
| SLC25A5 (ANT2) | ADP/ATP carrier; may influence Pi homeostasis | Potential crosstalk with Pi transport |
| SLC25A6 (ANT3) | ADP/ATP carrier; affects mitochondrial energetics | Modulates Pi availability |
| SLC25A10 (DIC) | Dicarboxylate carrier; transports phosphate and dicarboxylates | Alternative Pi transport pathway |
| SLC25A11 (OGC) | Oxoglutarate carrier; may transport phosphate | Related carrier family member |
| SLC25A12 (AGC1) | Aspartate/glutamate carrier; linked to Pi metabolism | Indirect role in Pi homeostasis |
| SLC25A13 (AGC2) | Aspartate/glutamate carrier; affects mitochondrial metabolism | Indirect role |
| SLC25A15 (ORC1) | Ornithine carrier; may influence Pi transport | Related carrier |
| SLC25A17 (PMP34) | Peroxisomal carrier; not mitochondrial | Outgroup for comparative studies |
| SLC25A20 (CACT) | Carnitine/acylcarnitine carrier; affects fatty acid oxidation | Indirect effect on Pi demand |
| SLC25A22 (GC1) | Glutamate carrier; linked to Pi metabolism | Indirect role |
| SLC25A23 (APC2) | ATP-Mg/Pi carrier; transports phosphate | Direct Pi transport |
| SLC25A24 (APC1) | ATP-Mg/Pi carrier; transports phosphate | Direct Pi transport |
| SLC25A25 (APC3) | ATP-Mg/Pi carrier; transports phosphate | Direct Pi transport |
| SLC25A31 (ANT4) | ADP/ATP carrier; affects Pi transport | Indirect role |
How Is mitochondrial phosphate ion transmembrane transport Regulated?
The transport of phosphate across the mitochondrial inner membrane is regulated at multiple levels. The expression of SLC25A3 is controlled by tissue-specific promoters and transcription factors such as NRF-1 and TFAM, which coordinate mitochondrial biogenesis. Additionally, the transport activity of PiC can be modulated by the proton gradient, pH, and the availability of substrates like ADP and ATP. Post-translational modifications, including phosphorylation, may also regulate PiC function, although specific sites remain to be fully characterized. Furthermore, the interaction of PiC with other mitochondrial carriers, such as the ADP/ATP carrier, can influence overall phosphate flux.
mitochondrial phosphate ion transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A3 | Mitochondrial phosphate carrier deficiency | Knockout mice, patient-derived fibroblasts, iPSC-derived cardiomyocytes |
| PINK1 | Parkinson's disease, colon cancer | PINK1 knockout cell lines, mouse models |
| SLC25A23 | Calcium signaling, cancer | Knockout and overexpression models |
| SLC25A24 | ATP-Mg/Pi transport, metabolic disorders | Point mutation knock-in models |
| SLC25A25 | Mitochondrial metabolism, diabetes | Tissue-specific knockout mice |
Mitochondrial Phosphate Carrier Deficiency
Mutations in SLC25A3 cause mitochondrial phosphate carrier deficiency, a rare autosomal recessive disorder characterized by lactic acidosis, hypertrophic cardiomyopathy, and muscular hypotonia. These mutations impair Pi transport, leading to reduced ATP synthesis and energy failure in high-demand tissues.
Cancer Metabolism
Altered mitochondrial phosphate transport supports the metabolic reprogramming of cancer cells. For example, PINK1 deficiency, which affects mitochondrial function, facilitates iron accumulation and colon tumorigenesis, highlighting the interplay between mitochondrial transport and cancer. Targeting Pi transport may offer therapeutic opportunities in cancers with high metabolic demands.
Neurodegenerative Disorders
Mitochondrial dysfunction, including impaired phosphate transport, is implicated in neurodegenerative diseases such as Parkinson's disease. PINK1, a key player in mitochondrial quality control, is linked to iron accumulation and neuronal death, suggesting that Pi transport may influence neurodegeneration.
From mitochondrial phosphate ion transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of PiC loss on mitochondrial function? | SLC25A3 knockout cell lines (e.g., HEK293, HeLa) |
| How do specific mutations affect Pi transport? | Point-mutation knock-in of SLC25A3 (e.g., E137Q, D39N) |
| Can we visualize PiC localization and dynamics? | Tagged knock-in (e.g., GFP-SLC25A3) in cell lines |
| Does overexpression of PiC enhance ATP production? | SLC25A3 overexpression in cell lines or primary cells |
| What is the role of PiC in cancer metabolism? | Xenograft models with SLC25A3 knockout or overexpression |
| How does PiC interact with other mitochondrial carriers? | Co-immunoprecipitation and proximity labeling in knockout backgrounds |
How to Study the mitochondrial phosphate ion transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive phosphate uptake | Transport rate and kinetics | Isolated mitochondria or proteoliposomes |
| Site-directed mutagenesis | Effect of specific residues on transport | Structure-function studies of PiC |
| Cryo-EM | High-resolution structure | Mechanistic insights into conformational changes |
| Live-cell imaging with Pi sensors | Real-time mitochondrial Pi levels | Cellular dynamics under stress |
| Co-immunoprecipitation | Protein-protein interactions | Identifying PiC binding partners |
| RNA-seq | Gene expression changes | Knockout or overexpression studies |
| Proteomics | Protein abundance and modifications | Post-translational regulation of PiC |
| Metabolic flux analysis | ATP synthesis and oxygen consumption | Functional consequences of Pi transport |
Transport Assays
Phosphate transport activity can be measured using isolated mitochondria or proteoliposomes reconstituted with purified PiC. Radioactive 32P-labeled phosphate uptake assays are standard for quantifying transport rates and kinetics [4, 8].
Mutagenesis and Functional Analysis
Site-directed mutagenesis of SLC25A3 followed by transport assays in yeast or mammalian cells allows identification of residues critical for Pi binding and translocation. Reversion of inhibitory mutations has been used to map transmembrane helices [4, 5].
Structural Biology
Cryo-electron microscopy and X-ray crystallography can determine the structure of PiC in different conformations, providing insights into the transport mechanism. Homology modeling based on other mitochondrial carriers is also useful.
Live-Cell Imaging
Genetically encoded fluorescent sensors for phosphate (e.g., Pi-sensitive GFP) can monitor mitochondrial Pi dynamics in real time. Tagged PiC allows tracking of protein localization and dynamics.
How CRISPR Can Be Used to Study GO:1990547 mitochondrial phosphate ion transmembrane transport
Knockout
CRISPR-Cas9 knockout of SLC25A3 in cell lines (e.g., HEK293, HeLa) abolishes Pi transport, leading to reduced mitochondrial ATP synthesis and altered metabolism. These models are valuable for studying the essential role of PiC and for identifying compensatory pathways.
Point Mutation
Introducing specific point mutations (e.g., E137Q, D39N) into SLC25A3 via CRISPR-mediated homology-directed repair allows precise dissection of residues involved in proton coupling and substrate binding. Such models can reveal partial loss-of-function or gain-of-function phenotypes [4, 8].
Knock-in
Knock-in of tagged SLC25A3 (e.g., GFP or HA) enables visualization and affinity purification of the carrier in its native context. This approach is useful for studying protein interactions, localization, and dynamics without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of SLC25A3 can increase Pi transport capacity, enhancing ATP production and altering cellular metabolism. These models are used to test whether increased Pi uptake promotes proliferation or survival under stress.
How EDITGENE Supports mitochondrial phosphate ion transmembrane transport Research
Researchers studying mitochondrial phosphate ion transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in Pi homeostasis, mitochondrial function, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial phosphate ion transmembrane transport research.
Frequently Asked Questions About mitochondrial phosphate ion transmembrane transport
What is mitochondrial phosphate ion transmembrane transport?
It is the process of moving phosphate ions across the mitochondrial membrane, primarily mediated by the mitochondrial phosphate carrier (PiC/SLC25A3), as defined by GO:1990547.
What genes are involved in mitochondrial phosphate ion transmembrane transport?
The key gene is SLC25A3, which encodes the mitochondrial phosphate carrier. Other SLC25 family members like SLC25A23, SLC25A24, and SLC25A25 also transport phosphate.
Why is mitochondrial phosphate transport important?
It is essential for ATP synthesis, phosphate homeostasis, and mitochondrial metabolism. Defects can cause mitochondrial diseases and contribute to cancer [3, 7].
How is mitochondrial phosphate transport regulated?
It is regulated by the proton gradient, substrate availability, and expression levels of SLC25A3, which are controlled by mitochondrial biogenesis transcription factors [3, 8].
What diseases are associated with defects in mitochondrial phosphate transport?
Mutations in SLC25A3 cause mitochondrial phosphate carrier deficiency, characterized by cardiomyopathy and lactic acidosis. It is also implicated in cancer and neurodegeneration [1, 3].
What methods are used to study mitochondrial phosphate transport?
Common methods include radioactive phosphate uptake assays, site-directed mutagenesis, cryo-EM, live-cell imaging with Pi sensors, and CRISPR-based genetic models [4, 5, 8].
Can CRISPR be used to study mitochondrial phosphate transport?
Yes, CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models are powerful tools to dissect the function of SLC25A3 and related genes [3, 4].
What is the role of SLC25A3 in cancer?
SLC25A3 supports cancer cell metabolism by providing phosphate for ATP synthesis and biosynthesis. Its expression is often altered in tumors.
How does PiC transport phosphate?
PiC functions as a proton-coupled symporter, using the proton gradient to drive phosphate uptake into the mitochondrial matrix.
What are the isoforms of SLC25A3?
SLC25A3 has two isoforms: isoform A (heart/muscle-specific) and isoform B (ubiquitous), generated by alternative splicing.
Conclusion
Mitochondrial phosphate ion transmembrane transport (GO:1990547) is a fundamental process for mitochondrial bioenergetics and cellular phosphate homeostasis. The mitochondrial phosphate carrier SLC25A3 is the primary mediator, and its dysfunction leads to severe mitochondrial diseases and contributes to cancer and neurodegeneration. Advanced CRISPR-based models, such as knockout, point mutation, and tagged knock-in, are invaluable for dissecting the molecular mechanism and physiological roles of this transport process. EDITGENE offers comprehensive services to support such research, from custom cell line generation to high-throughput screening and bioinformatics.
References
- 1. Arcos M et al.. 2025. PINK1-deficiency facilitates mitochondrial iron accumulation and colon tumorigenesis.. Autophagy 21(4):737-753 PMID: 39512202
- 3. Palmieri F et al.. 1993. Transmembrane topology, genes, and biogenesis of the mitochondrial phosphate and oxoglutarate carriers.. J Bioenerg Biomembr 25(5):493-501 PMID: 8132489
- 4. Phelps A et al.. 2001. Mitochondrial phosphate transport protein. Reversions of inhibitory conservative mutations identify four helices and a nonhelix protein segment with transmembrane interactions and Asp39, Glu137, and Ser158 as nonessential for transport.. Biochemistry 40(7):2080-6 PMID: 11329276
- 5. Phelps A et al.. 2004. Homodimeric mitochondrial phosphate transport protein. Transient subunit/subunit contact site between the transport relevant transmembrane helices A.. Biochemistry 43(20):6200-7 PMID: 15147204
- 7. Dimroth P et al.. 2008. ATP synthesis by decarboxylation phosphorylation.. Results Probl Cell Differ 45:153-84 PMID: 18049805
- 8. Phelps A et al.. 1996. Mitochondrial phosphate transport protein. replacements of glutamic, aspartic, and histidine residues affect transport and protein conformation and point to a coupled proton transport path.. Biochemistry 35(33):10757-62 PMID: 8718866
